Neuroendocrine prostate cancer is complex, comprising a wide spectrum of phenotypes, which has led to very different entities being inappropriately lumped together or assumed to behave like more common entities. Elucidating subtle differences is critical for treatment decision making, as this commentary describes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10911908 | PMC |
http://dx.doi.org/10.1093/oncolo/oyad344 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!